InflaRx N.V.
IFRX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001708688
No open-market purchases or sales by InflaRx N.V. insiders were filed in the last 90 days; 62 institutions reported holding it in 13F filings for Q2 2026, worth $211.6M in total; no superinvestor holds it.
13F holders, Q2 2021
Institutional positions in InflaRx N.V. as of Jun 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 37
- −5 vs. Q1 2021
- Shares held
- 11.2M
- −3.29M (−22.8%) vs. Q1 2021
- Total value
- $33.1M
- −$23.2M (−41.2%) vs. Q1 2021
- New holders
- 5
- 4 more added
- Sold out
- 10
- 15 more reduced
Compare with Q1 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting IFRX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 62 | $211.6M |
| Q1 2026 | 35 | $16.9M |
| Q4 2025 | 34 | $19.6M |
| Q3 2025 | 27 | $24.9M |
| Q2 2025 | 27 | $13.3M |
| Q1 2025 | 31 | $17.9M |
| Q4 2024 | 30 | $32.1M |
| Q3 2024 | 27 | $19.7M |
| Q2 2024 | 33 | $23.0M |
| Q1 2024 | 37 | $21.3M |
| Q4 2023 | 39 | $27.8M |
| Q3 2023 | 42 | $56.8M |
| Q2 2023 | 37 | $82.7M |
| Q1 2023 | 25 | $7.08M |
| Q4 2022 | 33 | $11.6M |
| Q3 2022 | 30 | $10.5M |
| Q2 2022 | 27 | $7.63M |
| Q1 2022 | 32 | $12.0M |
| Q4 2021 | 38 | $44.1M |
| Q3 2021 | 35 | $23.0M |
| Q2 2021 | 37 | $33.1M |
| Q1 2021 | 42 | $56.4M |
Institutions, Q2 2021
Shares, value and share of portfolio for each institution holding InflaRx N.V.; share changes are against Q1 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Suvretta Capital Management, LLC | 3,285,000 | $9.76M | 0.15% | 00.0% | Unchanged |
| Great Point Partners LLC | 2,200,000 | $6.53M | 1.46% | 00.0% | Unchanged |
| OrbiMed Advisors LLC | 1,064,118 | $3.16M | 0.03% | 00.0% | Unchanged |
| Morgan Stanley | 751,293 | $2.23M | 0.00% | +30,316+4.2% | Added |
| Ikarian Capital, LLC | 666,596 | $1.98M | 0.35% | −33,154−4.7% | Reduced |
| DAFNA Capital Management LLC | 600,000 | $1.78M | 0.37% | 00.0% | Unchanged |
| Laurion Capital Management LP | 500,000 | $1.49M | 0.02% | 00.0% | Unchanged |
| Kingdon Capital Management, L.L.C. | 400,000 | $1.19M | 0.18% | 00.0% | Unchanged |
| FNY Investment Advisers, LLC | 343,000 | $1.02M | 0.41% | −7,000−2.0% | Reduced |
| Bank Julius Baer & Co. Ltd, Zurich | 197,643 | $587.0K | 0.00% | +197,643 | New |
| QS Investors, LLC | 174,200 | $517.0K | 0.01% | 00.0% | Unchanged |
| Altium Capital Management LP | 161,206 | $479.0K | 0.11% | −613,394−79.2% | Reduced |
| Renaissance Technologies LLC | 134,283 | $399.0K | 0.00% | +10,936+8.9% | Added |
| Verition Fund Management LLC | 85,761 | $255.0K | 0.00% | −30,934−26.5% | Reduced |
| Boothbay Fund Management, LLC | 84,900 | $252.0K | 0.01% | −4,223−4.7% | Reduced |
| Franklin Street Advisors Inc | 75,100 | $223.0K | 0.02% | 00.0% | Unchanged |
| Birchview Capital, LP | 70,000 | $208.0K | 0.12% | 00.0% | Unchanged |
| Commonwealth of Pennsylvania Public School Empls Retrmt Sys | 49,800 | $148.0K | 0.00% | 00.0% | Unchanged |
| Gsa Capital Partners LLP | 46,633 | $139.0K | 0.02% | +46,633 | New |
| Susquehanna International Group, LLP | 33,664 | $100.0K | 0.00% | −25,807−43.4% | Reduced |
| Marquette Asset Management, LLC | 33,215 | $99.0K | 0.02% | +33,215 | New |
| Millennium Management LLC | 32,542 | $97.0K | 0.00% | +2,027+6.6% | Added |
| IPG Investment Advisors LLC | 25,900 | $76.9K | 0.02% | +25,900 | New |
| Raymond James Financial Services Advisors, Inc. | 23,346 | $69.0K | 0.00% | −3,698−13.7% | Reduced |
| Algert Global LLC | 23,010 | $68.0K | 0.02% | −11,630−33.6% | Reduced |
| Pacifica Partners Inc. | 20,585 | $61.0K | 0.05% | +8,000+63.6% | Added |
| Raymond James & Associates | 19,919 | $59.0K | 0.00% | −21,574−52.0% | Reduced |
| ETF Managers Group, LLC | 12,931 | $38.0K | 0.00% | −395−3.0% | Reduced |
| Personal Cfo Solutions, LLC | 11,000 | $33.0K | 0.01% | −2,000−15.4% | Reduced |
| Occudo Quantitative Strategies LP | 10,762 | $32.0K | 0.00% | −315−2.8% | Reduced |
| Citadel Advisors LLC | 10,836 | $32.0K | 0.00% | +10,836 | New |
| BlackRock Inc. | 7,419 | $22.0K | 0.00% | 00.0% | Unchanged |
| Simplex Trading, LLC | 3,846 | $11.0K | 0.00% | −1,014−20.9% | Reduced |
| UBS Group AG | 1,245 | $4.00K | 0.00% | −5,284−80.9% | Reduced |
| Steward Partners Investment Advisory, LLC | 1,200 | $4.00K | 0.00% | −250−17.2% | Reduced |
| Harbour Investments, Inc. | 200 | $1.00K | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 30 | $0 | 0.00% | 00.0% | Unchanged |
| Sphera Funds Management Ltd. | 0 | $0 | 0.00% | −1,000,000−100.0% | Sold out |
| CVI Holdings, LLC | 0 | $0 | 0.00% | −836,881−100.0% | Sold out |
| Granite Point Capital Management, L.P. | 0 | $0 | 0.00% | −381,086−100.0% | Sold out |
| Eversept Partners, LP | 0 | $0 | 0.00% | −268,634−100.0% | Sold out |
| Alyeska Investment Group, L.P. | 0 | $0 | 0.00% | −150,000−100.0% | Sold out |
| Baker Bros. Advisors LP | 0 | $0 | 0.00% | −138,040−100.0% | Sold out |
| Maven Securities LTD | 0 | $0 | 0.00% | −110,573−100.0% | Sold out |
| Engineers Gate Manager LP | 0 | $0 | 0.00% | −13,020−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −6−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −100−100.0% | Sold out |